Cargando…
Combination of Selected MET and EGFR Inhibitors Decreases Melanoma Cells’ Invasive Abilities
We have previously shown that combination of foretinib, an inhibitor of MET (hepatocyte growth factor receptor), with gefitinib or lapatinib, inhibitors of EGFR (epidermal growth factor receptor), has a synergistic cytotoxic effect on melanoma cells. However, there are cancer cells resistant to drug...
Autores principales: | Simiczyjew, Aleksandra, Pietraszek-Gremplewicz, Katarzyna, Dratkiewicz, Ewelina, Podgórska, Marta, Matkowski, Rafał, Ziętek, Marcin, Nowak, Dorota |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6792435/ https://www.ncbi.nlm.nih.gov/pubmed/31649529 http://dx.doi.org/10.3389/fphar.2019.01116 |
Ejemplares similares
-
Expression level of EGFR and MET receptors regulates invasiveness of melanoma cells
por: Pietraszek‐Gremplewicz, Katarzyna, et al.
Publicado: (2019) -
Characterization of Melanoma Cell Lines Resistant to Vemurafenib and Evaluation of Their Responsiveness to EGFR- and MET-Inhibitor Treatment
por: Dratkiewicz, Ewelina, et al.
Publicado: (2019) -
Melanoma stimulates the proteolytic activity of HaCaT keratinocytes
por: Mazurkiewicz, Justyna, et al.
Publicado: (2022) -
Melanoma cells with diverse invasive potential differentially induce the activation of normal human fibroblasts
por: Mazurkiewicz, Justyna, et al.
Publicado: (2022) -
Melanoma cells induce dedifferentiation and metabolic changes in adipocytes present in the tumor niche
por: Simiczyjew, Aleksandra, et al.
Publicado: (2023)